Skip to content

Yulanyou's real world research program for HP infected people

A prospective, open real world study on the safety and efficacy of yulanyou in patients with HP infection

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047732
Enrollment
Unknown
Registered
2021-06-24
Start date
2021-06-23
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HP infection

Interventions

Case series:No

Sponsors

Beijing Yuanxin Technology Group Co. LTD
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old men and women; 2. HP infection was diagnosed; 3. After obtaining ethical consent, the study has purchased and taken yulanyou HP egg yolk powder solid drink through regular way, and the quantity is unlimited; 4. The patient understands and agrees to participate in the project and voluntarily sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic constitution or allergic to eggs and other known ingredients of the product; 2. Participated in any other intervention clinical trials within one month before the study; 3. Other patients considered unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
The rate of HP negative change after treatment;

Secondary

MeasureTime frame
The remission of main disease symptoms was better than that of baseline;The change of bacterial load was compared with baseline;

Countries

China

Contacts

Public ContactCheng Hong

Peking University First Hospital

chenghong1969@163.com+86 13501345394

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026